Subscribe To
Jeff bezos bought amazon stock for the first time in over 2 decades. he may be engaging in elon musk-style trolling.
In a surprising move, Jeff Bezos bought a single share of Amazon for about $115 in late May. Bezos may have been engaging in some Elon Musk-style trol...
June 12, 2023, 7:08 am
Netflix subscriptions rise as password-sharing crackdown takes effect
Netflix has seen a rise in new subscribers in the U.S. in recent days after rolling out its password sh...
June 9, 2023, 5:44 pm
Fx option expiries for 9 june 10am new york cut
There are a couple to take note of, as highlighted in bold.They are both for USD/JPY at 139.00 and 14.00 respectively and the expiries should keep pri...
June 9, 2023, 5:41 am
Airbus on track to meet delivery target – broker
Airbus Group (EPA:AIR) is on track to meet delivery targets this year, after boosting the number of aircraft r...
June 8, 2023, 10:03 am
Meta's whatapp launches channels feature for organizations to message all their followers at once
WhatsApp is rolling out a new Channels feature that lets users follow news feeds from businesses, chari...
June 8, 2023, 9:16 am
Large fx option expiries in focus for usd/jpy and eur/usd today
I provided the details on the expiries earlier here but just in case you missed it:"The first being for EUR/USD and that sits closer to the 1.0700 mar...
June 8, 2023, 7:41 am
Fx option expiries for 8 june 10am new york cut
There are a couple of big ones to take note of, as highlighted in bold.The first being for EUR/USD and that sits closer to the 1.0700 mark. As such, i...
June 8, 2023, 5:10 am
Why stitch fix stock soared today
Stitch Fix is controlling costs better and has plans to continue to pare back its operating expenses. Q...
June 7, 2023, 11:12 am
Figs cfo says managing through volatility requires controlling what you can
Amid today's hostile macroclimate, the CFO role has taken on increased importance. Daniella Turenshine, chief financial officer at direct-to-consumer ...
June 6, 2023, 5:46 pm
Healthlynked revamps app to emphasize smooth communication between patients and healthcare providers
HealthLynked (OTCQB:HLYK) Corp said it is rolling out major updates to its HealthLynked (OTCQB:HLYK) ap...
June 6, 2023, 9:08 am
Fx option expiries for 6 june 10am new york cut
There are a couple to take note of for today, as highlighted in bold.The first being for EUR/USD, with a large set of expiries sitting at around the 1...
June 6, 2023, 5:50 am
Why shares of day one pharmaceuticals are up monday
Day One has begun a rolling NDA for its candidate DAY101 as a monotherapy for relapsed or progressive p...
June 5, 2023, 12:30 pm
Novo nordisk in talks to buy controlling stake in biocorp
Novo Nordisk NVO, -0.53% has entered into exclusive negotiations to acquire a controlling stake in Fren...
June 5, 2023, 8:40 am
Ivw: an abundance of alternatives
IVW is efficient at tracking its benchmark but there are superior alternatives in terms of fees and past performance. The ETF may not be suitable for ...
June 5, 2023, 1:54 am
Day one announces new firefly-1 data for tovorafenib (day101) and initiation of rolling nda submission to fda for relapsed or progressive pediatric low-grade glioma
Overall response rate (ORR) of 67% and clinical benefit rate (CBR) of 93% in 69 heavily pretreated RANO-HGG evaluable patients The Company expects to ...
June 4, 2023, 4:45 pm
Apexigen announces phase 2 data evaluating sotigalimab, its cd40 agonist antibody, in combination with doxorubicin in patients with advanced soft tissue sarcoma presented at the american society of cl
– Marked increases in overall survival observed across soft tissue sarcoma patients – – Demonstrated improvement of median progression free surv...
June 3, 2023, 12:00 pm
Apexigen announces phase 2 data evaluating sotigalimab, its cd40 agonist antibody, in combination with doxorubicin in patients with advanced soft tissue sarcoma presented at the american society of cl
– Marked increases in overall survival observed across soft tissue sarcoma patients – – Demonstrated improvement of median progression free surv...
June 3, 2023, 12:00 pm
Apexigen announces phase 2 data evaluating sotigalimab, its cd40 agonist antibody, in combination with doxorubicin in patients with advanced soft tissue sarcoma presented at the american society of cl
– Marked increases in overall survival observed across soft tissue sarcoma patients – – Demonstrated improvement of median progression free surv...
June 3, 2023, 12:00 pm
Apexigen announces phase 2 data evaluating sotigalimab, its cd40 agonist antibody, in combination with doxorubicin in patients with advanced soft tissue sarcoma presented at the american society of cl
– Marked increases in overall survival observed across soft tissue sarcoma patients – – Demonstrated improvement of median progression free surv...
June 3, 2023, 12:00 pm
Apexigen announces phase 2 data evaluating sotigalimab, its cd40 agonist antibody, in combination with doxorubicin in patients with advanced soft tissue sarcoma presented at the american society of cl
– Marked increases in overall survival observed across soft tissue sarcoma patients – – Demonstrated improvement of median progression free surv...
June 3, 2023, 12:00 pm